Peptides are small chains of amino acids that can signal your body to release or regulate hormones. Several peptides have been studied for their ability to naturally boost growth hormone (GH) production, which plays a key role in muscle growth, fat metabolism, recovery, and overall vitality.
Poor cognition
Decreased Body muscle mass
Poor sleep
Increase maximal O2 uptake
Slower recovery
Increased exercise tolerance/capacity
Higher body fat
Similar sx to TRT/HRT pts (minus the libido part)
Increased joint pain
Decreased bone mass density (spell BMD)
GH SECRETAGOGUE
GH RELEASE
1 – 2 mg
ONCE A WEEK
SUBCUTANEOUS
FASTED BEFORE BED OR UPON WAKING
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), developed to stimulate endogenous growth hormone (GH) secretion through a pulsatile pattern. It mimics the body’s natural hormone rhythms more closely.
Beyond fat loss, CJC-1295 has been studied for its role in improving lean body mass and overall body composition. Through repeated GH pulses, the peptide enhances protein synthesis, reduces fat accumulation, and maintains nitrogen retention.
Research on ipamorelin further supports its anabolic potential, showing an increase in bone mineral content and muscle retention in animal models subjected to catabolic stress.
CJC-1295 signals the anterior pituitary to produce GH
Co-administration with ipamorelin enhances GH release due to their complementary mechanisms of action.
Use Pulsatile Dosing Strategies: CJC-1295 promotes natural GH rhythms. Research protocols often emphasize intermittent administration to avoid GH desensitization.
GHRH ANALOG PEPTIDE
GH RELEASE
200-500 mcg
5 DAYS ON, 2 OFF
SUBCUTANEOUS
FASTED 2 BEFORE BED FIRST MEAL OR BEFORE BED OR SPLIT
Sermorelin binds to GHRH receptors on somatotroph cells in the anterior pituitary, stimulating a natural release of GH in a pulsatile manner. This mimics the body’s innate secretion patterns, thereby preserving regulatory feedback mechanisms between GH and insulin-like growth factor 1 (IGF-1). To trigger GH release, pairing Sermorelin with a GHRP (like Ipamorelin) is recommended.
Beyond muscle growth, Sermorelin has been studied for its influence on lipid metabolism. Growth hormone has well-documented lipolytic effects—breaking down stored triglycerides in adipose tissue for energy use.
THE OVERALL BENEFITS TO YOU.
Sermorelin’s anabolic and metabolic effects are thought to be most effective when paired with structured physical activity and nutrient-dense diets. Resistance training can synergize with GH-induced muscle growth, while proper protein intake ensures availability of amino acids for tissue repair and growth.
GHRH ANALOG PEPTIDE
FAT REDUCTION
1 – 2 mg
DAILY
SUBCUTANEOUS
TAKEN BEFORE BEDTIME
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog used primarily for reducing visceral fat and improving metabolic health. It the only FDA-approved peptide for reducing visceral adipose tissue (VAT) in HIV-associated lipodystrophy.
It mimics hypothalamic GHRH, acting at the anterior pituitary to signal growth hormone production, earning its reputation as the gold standard for stimulating endogenous GH.
POTENT GH SECRETAGOGUE
GH STIMULATION
100 mcg (3 X A DAY)
3 TIMES A DAY FOR 20 WEEKS
SUBCUTANEOUS
Hexarelin is a synthetic peptide designed to significantly increase growth hormone (GH) release. Unlike some other peptides, Hexarelin has been shown to influence not only muscle and fat metabolism but also cardiovascular and anti-aging pathways.
Hexarelin inhibits somatostatin, a hormone that restricts GH release. This unlocks the pituitary’s stored GH, allowing a potent GH pulse. It does not promote GH synthesis, so pairing it with a GHRH (e.g., CJC-1295, Sermorelin, Tesamorelin) is essential for full GH-axis stimulation
Works best with consistent use over a period of time (chronic dosing has shown more stable results compared to short bursts).
Combines well with exercise and a balanced diet, which can amplify its metabolic and muscle-preserving benefits.
SELECTIVE GH SECRETAGOGUE
GH STIMULATION
200 – 300 mcg
5 DAYS ON, 2 OFF
SUBCUTANEOUS
Ipamorelin is part of a class of compounds known as growth hormone secretagogues (GHSs), developed to stimulate the release of growth hormone (GH) from the pituitary gland.
Unlike earlier secretagogues, Ipamorelin is highly selective and exhibits fewer off-target effects. It is often combined with other agents like CJC-1295 to enhance the pulsatile release of GH over an extended duration.
Although Ipamorelin’s role in metabolism is significant on its own, experimental findings suggest amplified results when paired with structured dietary protocols and exercise models.
These statements have not been evaluated by the Food and Drug Administration. The products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.
Some peptides are not FDA-approved for anti-aging, weight loss, or wellness indications. Some have FDA approval for very specific conditions (e.g., tesamorelin for HIV-related lipodystrophy), but using them outside of that is considered off-label.
Some peptides are considered investigational and are only available via prescription from a licensed provider.
The content on this website is for informational and educational purposes only and should not be considered medical advice.
Individual results may vary. Always consult with your healthcare provider before starting any new treatment.
Certain peptides are only available through compounding pharmacies.
Compounded medications are not FDA-approved but are prepared under strict regulatory standards with a prescription.
Some therapies discussed involve off-label use of FDA-approved medications or investigational compounds.
Off-label use means the medication is being used in a manner not specifically approved by the FDA.